Hani Gabra

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Rucaparib Maintenance Treatment, Medicine, Recurrent Ovarian Carcinoma +7

Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines

Kyle Ellrott, Matthew H. Bailey, Gordon Saksena et al. · Cell Systems · 2018 · 895 citations · Full text

Engineering, Genetics, Genomics +17

Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

P. Vasey, Gordon C. Jayson, Amanda Gordon et al. · JNCI Journal of the National Cancer Institute · 2004 · 624 citations · Full text

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

Franz X. Schaub, Varsha Dhankani, Ashton C. Berger et al. · Cell Systems · 2018 · 434 citations · Full text

Copy number signatures and mutational processes in ovarian carcinoma

Geoff Macintyre, Teodora Goranova, Dilrini De Silva et al. · Nature Genetics · 2018 · 433 citations · Full text

Somatic Variant, Tumor Heterogeneity, Pathology +2